Creative Planning Exact Sciences Corp Call Options Transaction History

Creative Planning

  • $93.6 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 10, 2021
BUY
$90.24 - $124.05 $135,360 - $186,075
1,500 Added 187.5%
2,300 $8,000
Q2 2021

Aug 04, 2021
BUY
$93.66 - $139.27 $37,464 - $55,708
400 Added 100.0%
800 $8,000
Q3 2020

Nov 05, 2020
BUY
$72.92 - $102.01 $21,876 - $30,603
300 Added 300.0%
400 $4,000
Q1 2018

Apr 18, 2018
BUY
$39.82 - $57.53 $3,982 - $5,753
100 New
100 $0

Others Institutions Holding EXAS

# of Institutions
610
Shares Held
166M
Call Options Held
1.93M
Put Options Held
1.23M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email